| IL6 trans-signaling promotes KRAS-driven lung carcinogenesis GD Brooks, L McLeod, S Alhayyani, A Miller, PA Russell, W Ferlin, ... Cancer research 76 (4), 866-876, 2016 | 106 | 2016 |
| Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma A Miller, L McLeod, S Alhayyani, A Szczepny, DN Watkins, W Chen, ... Oncogene 36 (21), 3059-3066, 2017 | 97 | 2017 |
| ADAM 17 selectively activates the IL‐6 trans‐signaling/ERK MAPK axis in KRAS‐addicted lung cancer MI Saad, S Alhayyani, L McLeod, L Yu, M Alanazi, V Deswaerte, K Tang, ... EMBO molecular medicine 11 (4), e9976, 2019 | 77 | 2019 |
| Therapeutic targeting of the IL-6 trans-signaling/mechanistic target of rapamycin complex 1 axis in pulmonary emphysema SM Ruwanpura, L McLeod, LF Dousha, HJ Seow, S Alhayyani, MD Tate, ... American journal of respiratory and critical care medicine 194 (12), 1494-1505, 2016 | 54 | 2016 |
| Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancer S Alhayyani, L McLeod, AC West, JJ Balic, C Hodges, L Yu, JA Smith, ... Oncogene 41 (6), 809-823, 2022 | 5 | 2022 |
| BLOCKADE OF TACE MITIGATES LUNG ADENOCARCINOMA M Saad, S Alhayyani, L Mcleod, L Yu, C Garbers, S Ruwanpura, I Sagi, ... RESPIROLOGY 24, 82-82, 2019 | | 2019 |
| P3. 07-002 Blocking of ADAM17 Mitigates Kras-Induced Lung Adenocarcinoma Possibly via Inhibition of IL-6 Trans-Signaling M Saad, S Alhayyani, L Mcleod, C Garbers, S Rose-John, S Ruwanpura, ... Journal of Thoracic Oncology 12 (11), S2298, 2017 | | 2017 |
| The Adam17/il-6 Trans-Signalling Axis As A Therapeutic Target In Lung Adenocarcinoma B Jenkins, S Alhayyani, G Brooks, A Miller, L McLeod, W Ferlin, ... C19. MOLECULAR MECHANISMS OF DYSREGULATED INFLAMMATION, PROLIFERATION, AND …, 2017 | | 2017 |
| C19 MOLECULAR MECHANISMS OF DYSREGULATED INFLAMMATION, PROLIFERATION, AND REPAIR IN THORACIC ONCOLOGY: The Adam17/il-6 Trans-Signalling Axis As A Therapeutic Target In Lung … B Jenkins, S Alhayyani, G Brooks, A Miller, L McLeod, W Ferlin, ... American Journal of Respiratory and Critical Care Medicine 195, 2017 | | 2017 |
| INTERLEUKIN-6 TRANS-SIGNALLING AS A NOVEL THERAPEUTIC TARGET AND A BIOMARKER FOR LUNG CANCER S Ruwanpura, G Brooks, L Mcleod, S Alhayyani, A Miller, W Ferlin, ... RESPIROLOGY 21, 50-50, 2016 | | 2016 |
| THE ROLE OF STAT3 SERINE PHOSPHORYLATION IN THE KRAS-INDUCED LUNG CANCER DEVELOPMENT S Alhayyani, S Ruwanpura, B Jenkins RESPIROLOGY 21, 48-48, 2016 | | 2016 |
| Oncogenic dependency on STAT3 serine phosphorylation in Kras mutant lung cancer and cachexia SMA ALHAYYANI Monash University, 0 | | |
